top of page
%20BIANCO.png)
%20BIANCO.png)
Reprogramming the solid tumor microenvironment
to unlock
the full potential of cancer immunotherapy
This is Lever Bio
Our Vision
Our vision is to unlock biotech innovation in immuno-oncology working with researchers, universities and research centers to ultimately improve patient outcomes.
Our Approach
We focus on reprogramming the solid tumor microenvironment to foster anti-cancer immune response enhancing the recruitment, activation and sustained function of cytotoxic T lymphocytes against solid tumors.
Our compounds aim to be solid tumor microenvironment reprogramming agents and T-cell fitness potentiators
Join Lever Bio in advancing promising research and driving innovative drug development in the immuno-oncology field
News & Updates
bottom of page